We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock
NEXI

Delisted

NEXI was delisted on the 11th of July, 2024.

Back to rankings

30 hedge funds and large institutions have $921K invested in NexImmune, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

6% less funds holding

Funds holding: 32 → 30 (-2)

27% less capital invested

Capital invested by funds: $1.26M → $921K (-$334K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
30
Holders Change
-2
Holders Change %
-6.25%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Comerica Bank
Comerica Bank
Texas
+$20.2K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$11.5K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$6.06K
4
Renaissance Technologies
Renaissance Technologies
New York
+$2.21K
5
BBA
Baader Bank Aktiengesellschaft
Germany
+$341

Top Sellers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$22.9K
2
Jane Street
Jane Street
New York
-$12.7K
3
HF
HRT Financial
New York
-$11K
4
DC
Davenport & Co
Virginia
-$7.33K
5
Millennium Management
Millennium Management
New York
-$3.21K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPC
1
Slate Path Capital
New York
$194K – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$168K – – –
AO
3
Allen Operations
New York
$134K – – –
ECG
4
EPIQ Capital Group
California
$82K – – –
RJA
5
Raymond James & Associates
Florida
$67.3K – – –
PNC Financial Services Group
6
PNC Financial Services Group
Pennsylvania
$66.4K – – –
First Manhattan
7
First Manhattan
New York
$31.3K – – –
MCM
8
M28 Capital Management
Connecticut
$28K – – –
CG
9
Caprock Group
Idaho
$21.7K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$21.6K +$11.5K +1,857 +75%
Vanguard Group
11
Vanguard Group
Pennsylvania
$20.4K – – –
Comerica Bank
12
Comerica Bank
Texas
$17.1K +$20.2K +3,257 New
Renaissance Technologies
13
Renaissance Technologies
New York
$14K +$2.21K +356 +16%
BCM
14
Bridgeway Capital Management
Texas
$10K – – –
Millennium Management
15
Millennium Management
New York
$9.33K -$3.21K -518 -22%
Bank of Montreal
16
Bank of Montreal
Ontario, Canada
$8.18K – – –
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$7.08K +$6.06K +976 +221%
TSS
18
Two Sigma Securities
New York
$4.58K -$466 -75 -8%
State Street
19
State Street
Massachusetts
$4.58K – – –
BBA
20
Baader Bank Aktiengesellschaft
Germany
$3.23K +$341 +55 +9%
Northern Trust
21
Northern Trust
Illinois
$2.66K – – –
Two Sigma Investments
22
Two Sigma Investments
New York
$2.12K -$3.1K -500 -55%
SSWM
23
Smith Salley Wealth Management
North Carolina
$2.1K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$1.34K – – –
Osaic Holdings
25
Osaic Holdings
Arizona
$210 +$99 +16 +67%
1
2

NEXI Hedge Fund Activity: Q3 2023 in Review

30 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q3 2023, worth a combined $921K — down 27% from $1.26M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NEXI and 2 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Comerica Bank, opening a new position worth an estimated $20.2K. The largest seller was Envestnet Asset Management, exiting entirely with an estimated $22.9K sold.

  • 30 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q3 2023, down from 32 in Q2 2023.
  • Funds reported $921K of NexImmune, Inc. Common Stock stock for Q3 2023, down 27% quarter-over-quarter.
  • 2 funds opened new NexImmune, Inc. Common Stock positions in Q3 2023 and 4 closed out, a net change of -2 holders.
  • The largest NexImmune, Inc. Common Stock buyer in Q3 2023 was Comerica Bank, an estimated $20.2K added.
  • The largest NexImmune, Inc. Common Stock seller in Q3 2023 was Envestnet Asset Management, an estimated $22.9K sold.

Based on aggregated 13F filings for Q3 2023.